GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2826 - 2850 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgG Patient 3 -180 mild
G75896PD
80
IgM Patient 3 -180 mild
G29011JC
80
IgM Patient 3 -180 mild
G73271MD
80
IgM Patient 3 -180 mild
G78074HX
80
IgM Patient 3 -180 mild
G82779CI
80
IgM Patient 3 11 mild
G08520NM
80
IgG Patient 4 12 mild
G29857RC
80
IgG Patient 1 22 moderate
G00057MO
79
IgM Patient 1 10 moderate
G36374CE
79
IgM Patient 1 10 moderate
G96865DJ
79
IgG Patient 2 24 mild
G51872EK
79
IgG Patient 2 24 mild
G72424VO
79
IgM Patient 3 11 mild
G47566FL
79
IgM Patient 4 12 mild
G57449OF
79
IgM Patient 1 22 moderate
G69912LP
78
IgM Patient 2 24 mild
G21320TF
78
IgM Patient 1 6 moderate
G92022ML
78
IgG Patient 2 3 mild
G24617OK
78
IgM Patient 3 -180 mild
G58969RU
78
IgM Patient 3 -180 mild
G62826CL
78
IgG Patient 3 4 mild
G48898TH
78
IgM Patient 3 4 mild
G86156UJ
78
IgM Patient 1 22 moderate
G32611KT
77
IgG Patient 2 3 mild
G53168IY
77
IgG Patient 3 11 mild
G39023AU
77

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024